The new test is reportedly much faster, less labor-intensive and cheaper than the currently available test. The new assay was also able to identify higher levels of the virus in people on antiretroviral therapy who appear to be cured than what had been previously estimated. The presence of HIV detected by the new test was also 70-fold larger than prior assessments.
“Globally there are substantial efforts to cure people of HIV by finding ways to eradicate this latent reservoir of virus that stubbornly persists in patients, despite our best therapies,” said Phalguni Gupta, PhD, professor and vice chair of Pitt Public Health’s Department of Infectious Diseases and Microbiology and the senior author of the study. “But those efforts aren’t going to progress if we don’t have tests that are sensitive and practical enough to tell doctors if someone is truly cured.”
More articles on infection control:
Minnesota measles outbreak reaches 70 cases, shows signs of slowing down
Study links flu infection with Parkinson’s disease risk
15 articles on antibiotic resistance published in May
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.